Concepedia

TLDR

Gaucher disease, an autosomal recessive glycolipid storage disorder, is most prevalent among Ashkenazi Jews, where a single A→G mutation at cDNA nt 1226 accounts for ~75 % of alleles, but about 25 % of mutant alleles remained unidentified until linkage analysis suggested a single additional mutation could explain most of them. The newly identified 84GG mutation introduces a single guanine insertion at cDNA nt 84, causing a frameshift that terminates translation prematurely, despite normal mRNA levels. The 84GG mutation accounts for most of the previously unidentified Jewish Gaucher alleles, together with the 1226 and 1448 mutations comprising 95 % of disease alleles in 71 patients, thereby enabling reliable DNA‑based screening for heterozygotes with minimal risk of missing at‑risk couples.

Abstract

Gaucher disease is an autosomal recessive glycolipid storage disease characterized by a deficiency of glucocerebrosidase. The disease is most common in persons of Ashkenazi Jewish ancestry and the most common mutation, accounting for about 75% of the mutant alleles in this population, is known to be an A----G substitution at cDNA nucleotide (nt) 1226. Screening for this disease has not been possible because nearly 25% of the mutant alleles had not been identified, but linkage analysis led to the suggestion that most of these could be accounted for by a single mutation. We now report the discovery of this mutation. The insertion of a single nucleotide, a second guanine at cDNA nt 84 (the 84GG mutation), has been detected in the 5' coding region of the glucocerebrosidase gene. The amount of mRNA produced is shown to be normal but since the frameshift produced early termination, no translation product is seen. This finding is consistent with the virtual absence of antigen found in patients carrying this mutation. The 84GG mutation accounts for most of the previously unidentified Gaucher disease mutations in Jewish patients. The common Jewish mutation at nt 1226, the 84GG mutation, and the less-common mutation at nt 1448 accounted for 95% of all of the Gaucher disease-producing alleles in 71 Jewish patients. This now makes it possible to screen for heterozygotes on a DNA level with a relatively low risk of missing couples at risk for producing infants with Gaucher disease.

References

YearCitations

Page 1